PPARγ Agonists Improve Survival and Neurocognitive Outcomes in Experimental Cerebral Malaria and Induce Neuroprotective Pathways in Human Malaria

Cerebral malaria (CM) is associated with a high mortality rate, and long-term neurocognitive impairment in approximately one third of survivors. Adjunctive therapies that modify the pathophysiological processes involved in CM may improve outcome over anti-malarial therapy alone. PPARγ agonists have...

Descripción completa

Detalles Bibliográficos
Autores principales: Serghides, Lena, McDonald, Chloe R., Lu, Ziyue, Friedel, Miriam, Cui, Cheryl, Ho, Keith T., Mount, Howard T. J., Sled, John G., Kain, Kevin C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946361/
https://www.ncbi.nlm.nih.gov/pubmed/24603727
http://dx.doi.org/10.1371/journal.ppat.1003980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946361/
https://www.ncbi.nlm.nih.gov/pubmed/24603727
http://dx.doi.org/10.1371/journal.ppat.1003980

Ejemplares similares